Proteomic analysis of cerebrospinal fluid extracellular vesicles reveals synaptic injury, inflammation, and stress response markers in HIV patients with cognitive impairment

Extracellular vesicles (EVs) are nano-sized particles present in most body fluids including cerebrospinal fluid (CSF). Little is known about CSF EV proteins in HIV+ individuals. Here, we characterize the CSF EV proteome in HIV+ subjects and its relationship to neuroinflammation, stress responses, an...

Full description

Saved in:
Bibliographic Details
Published inJournal of neuroinflammation Vol. 16; no. 1; pp. 254 - 19
Main Authors Guha, Debjani, Lorenz, David R., Misra, Vikas, Chettimada, Sukrutha, Morgello, Susan, Gabuzda, Dana
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 05.12.2019
BioMed Central
BMC
Subjects
Apolipoproteins
Astrocytes
Biomarkers
Blood-brain barrier
Body fluids
Brain
Brain mapping
Cell culture
Cell Line, Tumor
Cerebrospinal fluid
Chemokines
Choroid plexus
Cognition
Cognitive ability
Cognitive Dysfunction - cerebrospinal fluid
Cognitive Dysfunction - genetics
Cognitive Dysfunction - psychology
Cognitive impairment
CSF
Cytokines
Electron microscopy
Extracellular vesicles
Extracellular Vesicles - genetics
Extracellular Vesicles - metabolism
Female
Gene mapping
Genes
Glial cells
Glial fibrillary acidic protein
Heat shock proteins
HIV
HIV Infections - cerebrospinal fluid
HIV Infections - genetics
HIV Infections - psychology
HIV patients
Hsp70 protein
Human immunodeficiency virus
Humans
Hydrogen peroxide
Immunoblotting
Immunological synapses
Inflammation
Inflammation - cerebrospinal fluid
Inflammation - genetics
Inflammation - psychology
Male
Mass spectrometry
Mass spectroscopy
Microscopy
Middle Aged
Mitochondria
Multiple sclerosis
Nanoparticles
Neuronal-glial interactions
Neurons
Oxidative stress
Oxidative Stress - physiology
PARK7 protein
Pathogenesis
Peptide mapping
Peroxides
Proteins
Proteomes
Proteomics
Proteomics - methods
Scientific imaging
Shock
Spectroscopy
Synapses
Synapses - genetics
Synapses - metabolism
Massachusetts
Extracellular vesicles
HIV
CSF
Proteomics
Cognitive impairment
Online AccessGet full text

Cover

Abstract Extracellular vesicles (EVs) are nano-sized particles present in most body fluids including cerebrospinal fluid (CSF). Little is known about CSF EV proteins in HIV+ individuals. Here, we characterize the CSF EV proteome in HIV+ subjects and its relationship to neuroinflammation, stress responses, and HIV-associated neurocognitive disorders (HAND). CSF EVs isolated from 20 HIV+ subjects with (n = 10) or without (n = 10) cognitive impairment were characterized by electron microscopy, nanoparticle tracking analysis, immunoblotting, and untargeted LC/MS/MS mass spectrometry. Functional annotation was performed by gene ontology (GO) mapping and expression annotation using Biobase Transfac and PANTHER software. Cultured astrocytic U87 cells were treated with hydrogen peroxide for 4 h to induce oxidative stress and EVs isolated by ultracentrifugation. Selected markers of astrocytes (GFAP, GLUL), inflammation (CRP), and stress responses (PRDX2, PARK7, HSP70) were evaluated in EVs released by U87 cells following induction of oxidative stress and in CSF EVs from HIV+ patients by immunoblotting. Mass spectrometry identified 2727 and 1626 proteins in EV fractions and EV-depleted CSF samples, respectively. CSF EV fractions were enriched with exosomal markers including Alix, syntenin, tetraspanins, and heat-shock proteins and a subset of neuronal, astrocyte, oligodendrocyte, and choroid plexus markers, in comparison to EV-depleted CSF. Proteins related to synapses, immune/inflammatory responses, stress responses, metabolic processes, mitochondrial functions, and blood-brain barrier were also identified in CSF EV fractions by GO mapping. HAND subjects had higher abundance of CSF EVs and proteins mapping to GO terms for synapses, glial cells, inflammation, and stress responses compared to those without HAND. GFAP, GLUL, CRP, PRDX2, PARK7, and HSP70 were confirmed by immunoblotting of CSF EVs from subjects with HAND and were also detected in EVs released by U87 cells under oxidative stress. These findings suggest that CSF EVs derived from neurons, glial cells, and choroid plexus carry synaptic, immune/inflammation-related, and stress response proteins in HIV+ individuals with cognitive impairment, representing a valuable source for biomarker discovery.
AbstractList Background Extracellular vesicles (EVs) are nano-sized particles present in most body fluids including cerebrospinal fluid (CSF). Little is known about CSF EV proteins in HIV+ individuals. Here, we characterize the CSF EV proteome in HIV+ subjects and its relationship to neuroinflammation, stress responses, and HIV-associated neurocognitive disorders (HAND). Methods CSF EVs isolated from 20 HIV+ subjects with (n = 10) or without (n = 10) cognitive impairment were characterized by electron microscopy, nanoparticle tracking analysis, immunoblotting, and untargeted LC/MS/MS mass spectrometry. Functional annotation was performed by gene ontology (GO) mapping and expression annotation using Biobase Transfac and PANTHER software. Cultured astrocytic U87 cells were treated with hydrogen peroxide for 4 h to induce oxidative stress and EVs isolated by ultracentrifugation. Selected markers of astrocytes (GFAP, GLUL), inflammation (CRP), and stress responses (PRDX2, PARK7, HSP70) were evaluated in EVs released by U87 cells following induction of oxidative stress and in CSF EVs from HIV+ patients by immunoblotting. Results Mass spectrometry identified 2727 and 1626 proteins in EV fractions and EV-depleted CSF samples, respectively. CSF EV fractions were enriched with exosomal markers including Alix, syntenin, tetraspanins, and heat-shock proteins and a subset of neuronal, astrocyte, oligodendrocyte, and choroid plexus markers, in comparison to EV-depleted CSF. Proteins related to synapses, immune/inflammatory responses, stress responses, metabolic processes, mitochondrial functions, and blood-brain barrier were also identified in CSF EV fractions by GO mapping. HAND subjects had higher abundance of CSF EVs and proteins mapping to GO terms for synapses, glial cells, inflammation, and stress responses compared to those without HAND. GFAP, GLUL, CRP, PRDX2, PARK7, and HSP70 were confirmed by immunoblotting of CSF EVs from subjects with HAND and were also detected in EVs released by U87 cells under oxidative stress. Conclusions These findings suggest that CSF EVs derived from neurons, glial cells, and choroid plexus carry synaptic, immune/inflammation-related, and stress response proteins in HIV+ individuals with cognitive impairment, representing a valuable source for biomarker discovery.
Extracellular vesicles (EVs) are nano-sized particles present in most body fluids including cerebrospinal fluid (CSF). Little is known about CSF EV proteins in HIV+ individuals. Here, we characterize the CSF EV proteome in HIV+ subjects and its relationship to neuroinflammation, stress responses, and HIV-associated neurocognitive disorders (HAND).BACKGROUNDExtracellular vesicles (EVs) are nano-sized particles present in most body fluids including cerebrospinal fluid (CSF). Little is known about CSF EV proteins in HIV+ individuals. Here, we characterize the CSF EV proteome in HIV+ subjects and its relationship to neuroinflammation, stress responses, and HIV-associated neurocognitive disorders (HAND).CSF EVs isolated from 20 HIV+ subjects with (n = 10) or without (n = 10) cognitive impairment were characterized by electron microscopy, nanoparticle tracking analysis, immunoblotting, and untargeted LC/MS/MS mass spectrometry. Functional annotation was performed by gene ontology (GO) mapping and expression annotation using Biobase Transfac and PANTHER software. Cultured astrocytic U87 cells were treated with hydrogen peroxide for 4 h to induce oxidative stress and EVs isolated by ultracentrifugation. Selected markers of astrocytes (GFAP, GLUL), inflammation (CRP), and stress responses (PRDX2, PARK7, HSP70) were evaluated in EVs released by U87 cells following induction of oxidative stress and in CSF EVs from HIV+ patients by immunoblotting.METHODSCSF EVs isolated from 20 HIV+ subjects with (n = 10) or without (n = 10) cognitive impairment were characterized by electron microscopy, nanoparticle tracking analysis, immunoblotting, and untargeted LC/MS/MS mass spectrometry. Functional annotation was performed by gene ontology (GO) mapping and expression annotation using Biobase Transfac and PANTHER software. Cultured astrocytic U87 cells were treated with hydrogen peroxide for 4 h to induce oxidative stress and EVs isolated by ultracentrifugation. Selected markers of astrocytes (GFAP, GLUL), inflammation (CRP), and stress responses (PRDX2, PARK7, HSP70) were evaluated in EVs released by U87 cells following induction of oxidative stress and in CSF EVs from HIV+ patients by immunoblotting.Mass spectrometry identified 2727 and 1626 proteins in EV fractions and EV-depleted CSF samples, respectively. CSF EV fractions were enriched with exosomal markers including Alix, syntenin, tetraspanins, and heat-shock proteins and a subset of neuronal, astrocyte, oligodendrocyte, and choroid plexus markers, in comparison to EV-depleted CSF. Proteins related to synapses, immune/inflammatory responses, stress responses, metabolic processes, mitochondrial functions, and blood-brain barrier were also identified in CSF EV fractions by GO mapping. HAND subjects had higher abundance of CSF EVs and proteins mapping to GO terms for synapses, glial cells, inflammation, and stress responses compared to those without HAND. GFAP, GLUL, CRP, PRDX2, PARK7, and HSP70 were confirmed by immunoblotting of CSF EVs from subjects with HAND and were also detected in EVs released by U87 cells under oxidative stress.RESULTSMass spectrometry identified 2727 and 1626 proteins in EV fractions and EV-depleted CSF samples, respectively. CSF EV fractions were enriched with exosomal markers including Alix, syntenin, tetraspanins, and heat-shock proteins and a subset of neuronal, astrocyte, oligodendrocyte, and choroid plexus markers, in comparison to EV-depleted CSF. Proteins related to synapses, immune/inflammatory responses, stress responses, metabolic processes, mitochondrial functions, and blood-brain barrier were also identified in CSF EV fractions by GO mapping. HAND subjects had higher abundance of CSF EVs and proteins mapping to GO terms for synapses, glial cells, inflammation, and stress responses compared to those without HAND. GFAP, GLUL, CRP, PRDX2, PARK7, and HSP70 were confirmed by immunoblotting of CSF EVs from subjects with HAND and were also detected in EVs released by U87 cells under oxidative stress.These findings suggest that CSF EVs derived from neurons, glial cells, and choroid plexus carry synaptic, immune/inflammation-related, and stress response proteins in HIV+ individuals with cognitive impairment, representing a valuable source for biomarker discovery.CONCLUSIONSThese findings suggest that CSF EVs derived from neurons, glial cells, and choroid plexus carry synaptic, immune/inflammation-related, and stress response proteins in HIV+ individuals with cognitive impairment, representing a valuable source for biomarker discovery.
Extracellular vesicles (EVs) are nano-sized particles present in most body fluids including cerebrospinal fluid (CSF). Little is known about CSF EV proteins in HIV+ individuals. Here, we characterize the CSF EV proteome in HIV+ subjects and its relationship to neuroinflammation, stress responses, and HIV-associated neurocognitive disorders (HAND). CSF EVs isolated from 20 HIV+ subjects with (n = 10) or without (n = 10) cognitive impairment were characterized by electron microscopy, nanoparticle tracking analysis, immunoblotting, and untargeted LC/MS/MS mass spectrometry. Functional annotation was performed by gene ontology (GO) mapping and expression annotation using Biobase Transfac and PANTHER software. Cultured astrocytic U87 cells were treated with hydrogen peroxide for 4 h to induce oxidative stress and EVs isolated by ultracentrifugation. Selected markers of astrocytes (GFAP, GLUL), inflammation (CRP), and stress responses (PRDX2, PARK7, HSP70) were evaluated in EVs released by U87 cells following induction of oxidative stress and in CSF EVs from HIV+ patients by immunoblotting. Mass spectrometry identified 2727 and 1626 proteins in EV fractions and EV-depleted CSF samples, respectively. CSF EV fractions were enriched with exosomal markers including Alix, syntenin, tetraspanins, and heat-shock proteins and a subset of neuronal, astrocyte, oligodendrocyte, and choroid plexus markers, in comparison to EV-depleted CSF. Proteins related to synapses, immune/inflammatory responses, stress responses, metabolic processes, mitochondrial functions, and blood-brain barrier were also identified in CSF EV fractions by GO mapping. HAND subjects had higher abundance of CSF EVs and proteins mapping to GO terms for synapses, glial cells, inflammation, and stress responses compared to those without HAND. GFAP, GLUL, CRP, PRDX2, PARK7, and HSP70 were confirmed by immunoblotting of CSF EVs from subjects with HAND and were also detected in EVs released by U87 cells under oxidative stress. These findings suggest that CSF EVs derived from neurons, glial cells, and choroid plexus carry synaptic, immune/inflammation-related, and stress response proteins in HIV+ individuals with cognitive impairment, representing a valuable source for biomarker discovery.
Background Extracellular vesicles (EVs) are nano-sized particles present in most body fluids including cerebrospinal fluid (CSF). Little is known about CSF EV proteins in HIV+ individuals. Here, we characterize the CSF EV proteome in HIV+ subjects and its relationship to neuroinflammation, stress responses, and HIV-associated neurocognitive disorders (HAND). Methods CSF EVs isolated from 20 HIV+ subjects with (n = 10) or without (n = 10) cognitive impairment were characterized by electron microscopy, nanoparticle tracking analysis, immunoblotting, and untargeted LC/MS/MS mass spectrometry. Functional annotation was performed by gene ontology (GO) mapping and expression annotation using Biobase Transfac and PANTHER software. Cultured astrocytic U87 cells were treated with hydrogen peroxide for 4 h to induce oxidative stress and EVs isolated by ultracentrifugation. Selected markers of astrocytes (GFAP, GLUL), inflammation (CRP), and stress responses (PRDX2, PARK7, HSP70) were evaluated in EVs released by U87 cells following induction of oxidative stress and in CSF EVs from HIV+ patients by immunoblotting. Results Mass spectrometry identified 2727 and 1626 proteins in EV fractions and EV-depleted CSF samples, respectively. CSF EV fractions were enriched with exosomal markers including Alix, syntenin, tetraspanins, and heat-shock proteins and a subset of neuronal, astrocyte, oligodendrocyte, and choroid plexus markers, in comparison to EV-depleted CSF. Proteins related to synapses, immune/inflammatory responses, stress responses, metabolic processes, mitochondrial functions, and blood-brain barrier were also identified in CSF EV fractions by GO mapping. HAND subjects had higher abundance of CSF EVs and proteins mapping to GO terms for synapses, glial cells, inflammation, and stress responses compared to those without HAND. GFAP, GLUL, CRP, PRDX2, PARK7, and HSP70 were confirmed by immunoblotting of CSF EVs from subjects with HAND and were also detected in EVs released by U87 cells under oxidative stress. Conclusions These findings suggest that CSF EVs derived from neurons, glial cells, and choroid plexus carry synaptic, immune/inflammation-related, and stress response proteins in HIV+ individuals with cognitive impairment, representing a valuable source for biomarker discovery. Keywords: HIV, Cognitive impairment, CSF, Extracellular vesicles, Proteomics
Extracellular vesicles (EVs) are nano-sized particles present in most body fluids including cerebrospinal fluid (CSF). Little is known about CSF EV proteins in HIV+ individuals. Here, we characterize the CSF EV proteome in HIV+ subjects and its relationship to neuroinflammation, stress responses, and HIV-associated neurocognitive disorders (HAND). CSF EVs isolated from 20 HIV+ subjects with (n = 10) or without (n = 10) cognitive impairment were characterized by electron microscopy, nanoparticle tracking analysis, immunoblotting, and untargeted LC/MS/MS mass spectrometry. Functional annotation was performed by gene ontology (GO) mapping and expression annotation using Biobase Transfac and PANTHER software. Cultured astrocytic U87 cells were treated with hydrogen peroxide for 4 h to induce oxidative stress and EVs isolated by ultracentrifugation. Selected markers of astrocytes (GFAP, GLUL), inflammation (CRP), and stress responses (PRDX2, PARK7, HSP70) were evaluated in EVs released by U87 cells following induction of oxidative stress and in CSF EVs from HIV+ patients by immunoblotting. Mass spectrometry identified 2727 and 1626 proteins in EV fractions and EV-depleted CSF samples, respectively. CSF EV fractions were enriched with exosomal markers including Alix, syntenin, tetraspanins, and heat-shock proteins and a subset of neuronal, astrocyte, oligodendrocyte, and choroid plexus markers, in comparison to EV-depleted CSF. Proteins related to synapses, immune/inflammatory responses, stress responses, metabolic processes, mitochondrial functions, and blood-brain barrier were also identified in CSF EV fractions by GO mapping. HAND subjects had higher abundance of CSF EVs and proteins mapping to GO terms for synapses, glial cells, inflammation, and stress responses compared to those without HAND. GFAP, GLUL, CRP, PRDX2, PARK7, and HSP70 were confirmed by immunoblotting of CSF EVs from subjects with HAND and were also detected in EVs released by U87 cells under oxidative stress. These findings suggest that CSF EVs derived from neurons, glial cells, and choroid plexus carry synaptic, immune/inflammation-related, and stress response proteins in HIV+ individuals with cognitive impairment, representing a valuable source for biomarker discovery.
Abstract Background Extracellular vesicles (EVs) are nano-sized particles present in most body fluids including cerebrospinal fluid (CSF). Little is known about CSF EV proteins in HIV+ individuals. Here, we characterize the CSF EV proteome in HIV+ subjects and its relationship to neuroinflammation, stress responses, and HIV-associated neurocognitive disorders (HAND). Methods CSF EVs isolated from 20 HIV+ subjects with (n = 10) or without (n = 10) cognitive impairment were characterized by electron microscopy, nanoparticle tracking analysis, immunoblotting, and untargeted LC/MS/MS mass spectrometry. Functional annotation was performed by gene ontology (GO) mapping and expression annotation using Biobase Transfac and PANTHER software. Cultured astrocytic U87 cells were treated with hydrogen peroxide for 4 h to induce oxidative stress and EVs isolated by ultracentrifugation. Selected markers of astrocytes (GFAP, GLUL), inflammation (CRP), and stress responses (PRDX2, PARK7, HSP70) were evaluated in EVs released by U87 cells following induction of oxidative stress and in CSF EVs from HIV+ patients by immunoblotting. Results Mass spectrometry identified 2727 and 1626 proteins in EV fractions and EV-depleted CSF samples, respectively. CSF EV fractions were enriched with exosomal markers including Alix, syntenin, tetraspanins, and heat-shock proteins and a subset of neuronal, astrocyte, oligodendrocyte, and choroid plexus markers, in comparison to EV-depleted CSF. Proteins related to synapses, immune/inflammatory responses, stress responses, metabolic processes, mitochondrial functions, and blood-brain barrier were also identified in CSF EV fractions by GO mapping. HAND subjects had higher abundance of CSF EVs and proteins mapping to GO terms for synapses, glial cells, inflammation, and stress responses compared to those without HAND. GFAP, GLUL, CRP, PRDX2, PARK7, and HSP70 were confirmed by immunoblotting of CSF EVs from subjects with HAND and were also detected in EVs released by U87 cells under oxidative stress. Conclusions These findings suggest that CSF EVs derived from neurons, glial cells, and choroid plexus carry synaptic, immune/inflammation-related, and stress response proteins in HIV+ individuals with cognitive impairment, representing a valuable source for biomarker discovery.
ArticleNumber 254
Audience Academic
Author Morgello, Susan
Chettimada, Sukrutha
Guha, Debjani
Gabuzda, Dana
Lorenz, David R.
Misra, Vikas
Author_xml – sequence: 1
  givenname: Debjani
  surname: Guha
  fullname: Guha, Debjani
– sequence: 2
  givenname: David R.
  surname: Lorenz
  fullname: Lorenz, David R.
– sequence: 3
  givenname: Vikas
  surname: Misra
  fullname: Misra, Vikas
– sequence: 4
  givenname: Sukrutha
  surname: Chettimada
  fullname: Chettimada, Sukrutha
– sequence: 5
  givenname: Susan
  surname: Morgello
  fullname: Morgello, Susan
– sequence: 6
  givenname: Dana
  orcidid: 0000-0002-4964-5083
  surname: Gabuzda
  fullname: Gabuzda, Dana
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31805958$$D View this record in MEDLINE/PubMed
BookMark eNp1ks1u1TAQhSNURH_gAdggS2y6aEpsx46zQaoqoJUqwQLYWo4zvvUliYOdXLgPxTsy6W2hrUBe2Bqf-ZLjOYfZ3hAGyLKXtDilVMk3ibK6KvOC1jmVtMq3T7IDWpUsZ0Vd7t0772eHKa2LgjMh2bNsn1NViFqog-zXpxgmCL23xAym2yafSHDEQoQmhjR6LBLXzb4l8HOKxkLXzZ2JZAPJ2w4SibAB0yWStoMZJ-T4YT3H7QnurjN9byYfhhOktyRNEdLSkcYwJCC9id8gJlSSi8uvZEQpDFMiP_x0TWxYDX7yGyC-H42PPV49z546_Ba8uN2Psi_v330-v8ivPn64PD-7yq2QxZSrytCGl0XRlA1lrmKmcgqXNI0sVausY7VphCudhRKfwXAlhOFUUFU7EJQfZZc7bhvMWo_R459udTBe3xRCXGkTp8W_ZtIqwWtquG1L51rFpTO8EFAbUM5VyHq7Y41z00Nr0UY03QPow5vBX-tV2GipaimlQMDxLSCG7zOkSfc-LXMwA4Q5acYZq3gtaonS14-k6zBHHOGNSpWiEor9Va0MGsAxhWWwC1SfyaKqMVO8RNXpP1S4WsC0YBCdx_qDhlf3jf5xeBc2FFQ7gcVkpQhOWz_dxAPJvtO00Eus9S7WGmOtl1jrLXbSR5138P_3_AY7n_7n
CitedBy_id crossref_primary_10_1007_s13365_021_01009_4
crossref_primary_10_1016_j_bbih_2021_100235
crossref_primary_10_3390_biom12050619
crossref_primary_10_1080_23808993_2020_1812382
crossref_primary_10_1186_s12943_023_01741_x
crossref_primary_10_1038_s41598_020_80813_0
crossref_primary_10_3390_v12070700
crossref_primary_10_1186_s43556_021_00040_5
crossref_primary_10_3390_biomedicines9080931
crossref_primary_10_3389_fmolb_2023_1156821
crossref_primary_10_3390_ph14080811
crossref_primary_10_3390_biomedicines10040785
crossref_primary_10_3389_fneur_2020_580030
crossref_primary_10_3390_jmse12050793
crossref_primary_10_1080_20013078_2020_1809065
crossref_primary_10_1002_jex2_55
crossref_primary_10_1093_sleep_zsab058
crossref_primary_10_1038_s41598_024_80865_6
crossref_primary_10_3390_v15091829
crossref_primary_10_1002_smll_202409353
crossref_primary_10_1523_JNEUROSCI_1170_24_2024
crossref_primary_10_15252_embj_2020106389
crossref_primary_10_3390_biom15010032
crossref_primary_10_3390_biomedicines9030252
crossref_primary_10_1016_j_expneurol_2022_114149
crossref_primary_10_3389_fcell_2021_798054
crossref_primary_10_1007_s12017_022_08704_3
crossref_primary_10_3389_fcimb_2024_1423394
crossref_primary_10_1002_jev2_12158
crossref_primary_10_1016_j_nbd_2022_105734
crossref_primary_10_1212_WNL_0000000000011853
crossref_primary_10_3390_life14040508
crossref_primary_10_3390_v12101117
crossref_primary_10_1038_s41380_022_01619_2
crossref_primary_10_3233_JAD_201544
crossref_primary_10_3390_pharmaceutics14091848
crossref_primary_10_3389_dyst_2023_11053
crossref_primary_10_3389_fncel_2021_695899
crossref_primary_10_1002_advs_202305554
crossref_primary_10_1016_j_bbi_2020_11_037
crossref_primary_10_3390_v15041009
crossref_primary_10_3390_ijms252011170
crossref_primary_10_1002_jev2_12397
crossref_primary_10_3390_jcm13237031
crossref_primary_10_3389_fneur_2024_1479272
crossref_primary_10_3390_ijms221910855
crossref_primary_10_3390_ijms252413705
crossref_primary_10_1089_neu_2020_7332
crossref_primary_10_3390_diagnostics13081421
crossref_primary_10_1021_acsami_3c16839
crossref_primary_10_1002_pmic_202000118
crossref_primary_10_1080_23744235_2022_2149852
crossref_primary_10_1007_s12640_021_00425_y
crossref_primary_10_1021_acs_jproteome_0c00380
crossref_primary_10_1128_mBio_01871_20
crossref_primary_10_3390_v16010072
crossref_primary_10_3390_diagnostics10060349
crossref_primary_10_1007_s13346_025_01789_w
crossref_primary_10_3390_cells9081857
crossref_primary_10_3390_v15030794
crossref_primary_10_1186_s40168_023_01717_5
Cites_doi 10.1016/j.addr.2009.02.003
10.1111/j.1365-2990.2011.01215.x
10.1371/journal.pone.0201144
10.1212/WNL.0b013e318200d727
10.1098/rstb.2013.0510
10.3389/fnins.2016.00127
10.1016/j.bcp.2017.12.020
10.1038/nrn.2015.29
10.1016/j.brainres.2011.05.015
10.1038/s41419-018-0341-3
10.1093/infdis/jiu676
10.3389/fnagi.2019.00187
10.1021/pr070220c
10.1074/mcp.M114.038554
10.1016/j.jneuroim.2007.08.004
10.1016/j.ynstr.2016.02.005
10.1126/scisignal.aai7696
10.1186/s12014-016-9111-3
10.2174/1570162X12666140526114956
10.3389/fncel.2014.00100
10.1097/QAI.0b013e31815ace97
10.1038/s41598-018-23505-0
10.1371/journal.pone.0039572
10.1038/tp.2012.64
10.1097/QAD.0000000000002121
10.1007/s12035-017-0821-y
10.1038/s41598-017-01739-8
10.1002/pmic.201800257
10.1038/cddis.2016.467
10.1155/2017/1719050
10.1016/j.bbi.2017.04.024
10.1002/elps.200410140
10.1097/QAD.0000000000001595
10.1093/brain/awv346
10.1007/s00415-006-0481-8
10.3390/ijms18030538
10.1002/ana.22053
10.3390/v7072810
10.1186/1479-5876-10-5
10.3389/fncel.2018.00526
10.1038/s41598-018-25515-4
10.1172/JCI200318921
10.1186/1742-2094-11-68
10.1074/jbc.R116.757955
10.1001/archinte.166.1.64
10.1038/nrn.2015.1
10.3389/fnagi.2017.00317
10.1097/QAI.0000000000000756
10.1038/nature18928
10.1016/j.cca.2016.09.001
10.1212/01.WNL.0000287431.88658.8b
10.1097/QAI.0000000000000532
10.1097/QAD.0000000000000303
10.1093/infdis/jis326
10.1002/jms.229
10.3233/JAD-170953
10.1002/1615-9861(200103)1:3<444::AID-PROT444>3.0.CO;2-Q
10.1021/pr049750o
10.1016/1044-0305(94)80016-2
10.1155/2015/152926
10.1186/1471-2202-7-S1-S4
10.1097/QAD.0000000000001503
10.1016/j.jalz.2014.06.008
10.1186/1559-0275-9-3
10.3389/fnins.2017.00026
10.1002/prca.200700522
10.1016/j.meegid.2017.05.021
10.1016/j.neuroscience.2018.04.003
10.1097/QAD.0000000000000580
10.1371/journal.pone.0157160
10.1038/nrneurol.2016.53
10.1097/QAI.0b013e318256f3bc
10.1016/j.jprot.2014.04.028
10.1212/WNL.0000000000000492
10.1002/pmic.200300463
10.1080/20013078.2017.1369805
10.1080/14728222.2018.1501473
10.1038/nri855
10.1002/ana.23627
10.15252/emmm.201606271
10.1038/ncomms3123
10.4049/jimmunol.1102244
10.1016/j.tim.2012.03.009
10.3389/fphys.2012.00124
10.1186/s12987-018-0104-7
ContentType Journal Article
Copyright COPYRIGHT 2019 BioMed Central Ltd.
2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s). 2019
Copyright_xml – notice: COPYRIGHT 2019 BioMed Central Ltd.
– notice: 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s). 2019
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7T5
7TK
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12974-019-1617-y
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Immunology Abstracts
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni)
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Immunology Abstracts
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1742-2094
EndPage 19
ExternalDocumentID oai_doaj_org_article_26c85391a3cd4ffd836fa305e9ae8ff7
PMC6896665
A607997434
31805958
10_1186_s12974_019_1617_y
Genre Journal Article
GeographicLocations Massachusetts
GeographicLocations_xml – name: Massachusetts
GrantInformation_xml – fundername: NIMH NIH HHS
  grantid: U24 MH100925
– fundername: NIH HHS
  grantid: U24 MH100930
– fundername: NIH HHS
  grantid: U24 MH100928
– fundername: NIH HHS
  grantid: R01 MH097659
– fundername: NIMH NIH HHS
  grantid: U24 MH100930
– fundername: NIMH NIH HHS
  grantid: U24 MH100929
– fundername: NIMH NIH HHS
  grantid: U24 MH100931
– fundername: NIH HHS
  grantid: R01 DA040391
– fundername: NIH HHS
  grantid: U24 MH100925
– fundername: NIMH NIH HHS
  grantid: R01 MH097659
– fundername: ;
  grantid: R01 MH097659; R01 MH110259; R01 DA040391; U24 MH100930; U24 MH100931; U24 MH100928; U24 MH100929; U24 MH100925
GroupedDBID ---
0R~
29L
2WC
53G
5GY
5VS
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EBD
EBLON
EBS
EJD
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
TR2
TUS
UKHRP
WOQ
WOW
XSB
~8M
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
3V.
7T5
7TK
7XB
8FK
AZQEC
DWQXO
H94
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c560t-87a1b3400b4b12f72a7f8f8f6ab648d8cf29ab5f4fce4958a3855a315189fe513
IEDL.DBID 7X7
ISSN 1742-2094
IngestDate Wed Aug 27 01:26:12 EDT 2025
Thu Aug 21 18:03:31 EDT 2025
Fri Jul 11 13:45:32 EDT 2025
Fri Jul 25 22:57:26 EDT 2025
Tue Jun 17 21:50:52 EDT 2025
Tue Jun 10 20:36:47 EDT 2025
Thu Apr 03 06:59:44 EDT 2025
Tue Jul 01 02:54:31 EDT 2025
Thu Apr 24 22:51:55 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Extracellular vesicles
HIV
CSF
Proteomics
Cognitive impairment
Language English
License Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c560t-87a1b3400b4b12f72a7f8f8f6ab648d8cf29ab5f4fce4958a3855a315189fe513
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-4964-5083
OpenAccessLink https://www.proquest.com/docview/2328457582?pq-origsite=%requestingapplication%
PMID 31805958
PQID 2328457582
PQPubID 55345
PageCount 19
ParticipantIDs doaj_primary_oai_doaj_org_article_26c85391a3cd4ffd836fa305e9ae8ff7
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6896665
proquest_miscellaneous_2322739596
proquest_journals_2328457582
gale_infotracmisc_A607997434
gale_infotracacademiconefile_A607997434
pubmed_primary_31805958
crossref_citationtrail_10_1186_s12974_019_1617_y
crossref_primary_10_1186_s12974_019_1617_y
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-12-05
PublicationDateYYYYMMDD 2019-12-05
PublicationDate_xml – month: 12
  year: 2019
  text: 2019-12-05
  day: 05
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Journal of neuroinflammation
PublicationTitleAlternate J Neuroinflammation
PublicationYear 2019
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References TE Angel (1617_CR18) 2012; 9
C Thery (1617_CR26) 2002; 2
DE Terry (1617_CR91) 2003; 3
T Trotta (1617_CR78) 2018; 148
AN Valdez (1617_CR6) 2016; 4
A Sami Saribas (1617_CR39) 2017; 8
A Eden (1617_CR12) 2016; 11
MS Fiandaca (1617_CR21) 2015; 11
A Hubert (1617_CR43) 2015; 70
E Cassol (1617_CR10) 2014; 28
A Guldbrandsen (1617_CR55) 2014; 13
AT Jan (1617_CR29) 2017; 9
K Hayakawa (1617_CR88) 2016; 535
I Grant (1617_CR4) 2014; 82
G Schiera (1617_CR66) 2015; 2015
C Akay (1617_CR72) 2012; 38
AM Anderson (1617_CR13) 2015; 69
A Stuendl (1617_CR23) 2016; 139
M Grapp (1617_CR64) 2013; 4
D Saylor (1617_CR3) 2016; 12
R Ghidoni (1617_CR22) 2018; 62
1617_CR35
EM Kramer-Albers (1617_CR87) 2007; 1
SA Bellingham (1617_CR31) 2012; 3
JH Ellwanger (1617_CR33) 2017; 53
I Kadiu (1617_CR40) 2012; 189
S Kodidela (1617_CR41) 2018; 13
S Ranjit (1617_CR83) 2018; 22
AM Dickens (1617_CR9) 2015; 29
MB Khan (1617_CR44) 2016; 22
JK Eng (1617_CR53) 1994; 5
Y Ogata (1617_CR54) 2005; 4
E Tavazzi (1617_CR75) 2014; 12
J Chen (1617_CR69) 2014; 8
A Bandera (1617_CR15) 2019; 11
KR Spindler (1617_CR61) 2012; 20
A Bora (1617_CR19) 2014; 20
J Peng (1617_CR52) 2001; 36
A Yilmaz (1617_CR5) 2008; 47
S Chettimada (1617_CR34) 2018; 8
1617_CR49
P Davidsson (1617_CR56) 2001; 1
SH Ramirez (1617_CR71) 2018; 15
JL Welton (1617_CR24) 2017; 6
B Sun (1617_CR45) 2017; 31
AG Thompson (1617_CR48) 2018; 18
EA Heller (1617_CR70) 2012; 7
Y Xing (1617_CR76) 2017; 65
M Saenz-Cuesta (1617_CR80) 2014; 8
A Kamat (1617_CR11) 2012; 60
P Jeannin (1617_CR89) 2018; 8
MN Madison (1617_CR32) 2015; 7
SS Spudich (1617_CR59) 2017; 25
M Sathyanesan (1617_CR62) 2012; 2
FN Soria (1617_CR28) 2017; 11
M Basso (1617_CR65) 2016; 10
C Ubaida-Mohien (1617_CR20) 2017; 31
S Wittke (1617_CR90) 2005; 26
W Rozek (1617_CR17) 2007; 6
M Strazza (1617_CR60) 2011; 1399
A Gupta (1617_CR36) 2014; 11
I Begcevic (1617_CR57) 2016; 13
V Budnik (1617_CR79) 2016; 17
J de Wit (1617_CR67) 2016; 17
C Verderio (1617_CR77) 2012; 72
RK Heaton (1617_CR2) 2010; 75
S Letendre (1617_CR7) 2011; 19
JP Laspiur (1617_CR16) 2007; 192
KA Konadu (1617_CR42) 2015; 211
JM Street (1617_CR46) 2012; 10
S Balusu (1617_CR63) 2016; 8
D Guha (1617_CR50) 2019; 33
A Luarte (1617_CR73) 2017; 2017
S Nooka (1617_CR74) 2018; 9
R Pascua-Maestro (1617_CR85) 2018; 12
A Arakelyan (1617_CR38) 2017; 7
A Antinori (1617_CR51) 2007; 69
CK Petito (1617_CR58) 1999; 5
B Lau (1617_CR82) 2006; 166
D Chiasserini (1617_CR47) 2014; 106
AM Dickens (1617_CR37) 2017; 10
B Kalmar (1617_CR86) 2009; 61
JC McArthur (1617_CR1) 2010; 67
MB Pepys (1617_CR81) 2003; 111
D Frohlich (1617_CR84) 2014; 369
V Valcour (1617_CR8) 2012; 206
S Abdulle (1617_CR14) 2007; 254
J Howitt (1617_CR30) 2016; 291
J Lee (1617_CR25) 2016; 462
M H Rashed (1617_CR27) 2017; 18
G Brachya (1617_CR68) 2006; 7
References_xml – volume: 61
  start-page: 310
  year: 2009
  ident: 1617_CR86
  publication-title: Adv Drug Deliv Rev
  doi: 10.1016/j.addr.2009.02.003
– volume: 38
  start-page: 175
  year: 2012
  ident: 1617_CR72
  publication-title: Neuropathol Appl Neurobiol
  doi: 10.1111/j.1365-2990.2011.01215.x
– volume: 13
  start-page: e0201144
  year: 2018
  ident: 1617_CR41
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0201144
– volume: 75
  start-page: 2087
  year: 2010
  ident: 1617_CR2
  publication-title: Neurology
  doi: 10.1212/WNL.0b013e318200d727
– volume: 369
  start-page: 20130510
  year: 2014
  ident: 1617_CR84
  publication-title: Philos Trans R Soc Lond Ser B Biol Sci
  doi: 10.1098/rstb.2013.0510
– volume: 10
  start-page: 127
  year: 2016
  ident: 1617_CR65
  publication-title: Front Neurosci
  doi: 10.3389/fnins.2016.00127
– volume: 148
  start-page: 184
  year: 2018
  ident: 1617_CR78
  publication-title: Biochem Pharmacol
  doi: 10.1016/j.bcp.2017.12.020
– volume: 17
  start-page: 160
  year: 2016
  ident: 1617_CR79
  publication-title: Nat Rev Neurosci
  doi: 10.1038/nrn.2015.29
– volume: 1399
  start-page: 96
  year: 2011
  ident: 1617_CR60
  publication-title: Brain Res
  doi: 10.1016/j.brainres.2011.05.015
– volume: 9
  start-page: 317
  year: 2018
  ident: 1617_CR74
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-018-0341-3
– volume: 211
  start-page: 1712
  year: 2015
  ident: 1617_CR42
  publication-title: J Infect Dis
  doi: 10.1093/infdis/jiu676
– volume: 11
  start-page: 187
  year: 2019
  ident: 1617_CR15
  publication-title: Front Aging Neurosci
  doi: 10.3389/fnagi.2019.00187
– volume: 6
  start-page: 4189
  year: 2007
  ident: 1617_CR17
  publication-title: J Proteome Res
  doi: 10.1021/pr070220c
– volume: 13
  start-page: 3152
  year: 2014
  ident: 1617_CR55
  publication-title: Mol Cell Proteomics
  doi: 10.1074/mcp.M114.038554
– volume: 192
  start-page: 157
  year: 2007
  ident: 1617_CR16
  publication-title: J Neuroimmunol
  doi: 10.1016/j.jneuroim.2007.08.004
– volume: 4
  start-page: 44
  year: 2016
  ident: 1617_CR6
  publication-title: Neurobiol Stress
  doi: 10.1016/j.ynstr.2016.02.005
– volume: 10
  start-page: eaai7696
  year: 2017
  ident: 1617_CR37
  publication-title: Sci Signal
  doi: 10.1126/scisignal.aai7696
– volume: 13
  start-page: 11
  year: 2016
  ident: 1617_CR57
  publication-title: Clin Proteomics
  doi: 10.1186/s12014-016-9111-3
– volume: 5
  start-page: 670
  year: 1999
  ident: 1617_CR58
  publication-title: J Neuro-Oncol
– volume: 12
  start-page: 97
  year: 2014
  ident: 1617_CR75
  publication-title: Curr HIV Res
  doi: 10.2174/1570162X12666140526114956
– volume: 8
  start-page: 100
  year: 2014
  ident: 1617_CR80
  publication-title: Front Cell Neurosci
  doi: 10.3389/fncel.2014.00100
– volume: 47
  start-page: 168
  year: 2008
  ident: 1617_CR5
  publication-title: J Acquir Immune Defic Syndr
  doi: 10.1097/QAI.0b013e31815ace97
– volume: 8
  start-page: 5170
  year: 2018
  ident: 1617_CR89
  publication-title: Sci Rep
  doi: 10.1038/s41598-018-23505-0
– volume: 7
  start-page: e39572
  year: 2012
  ident: 1617_CR70
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0039572
– volume: 2
  start-page: e139
  year: 2012
  ident: 1617_CR62
  publication-title: Transl Psychiatry
  doi: 10.1038/tp.2012.64
– volume: 33
  start-page: 615
  year: 2019
  ident: 1617_CR50
  publication-title: AIDS
  doi: 10.1097/QAD.0000000000002121
– ident: 1617_CR49
  doi: 10.1007/s12035-017-0821-y
– volume: 7
  start-page: 1695
  year: 2017
  ident: 1617_CR38
  publication-title: Sci Rep
  doi: 10.1038/s41598-017-01739-8
– volume: 18
  start-page: e1800257
  year: 2018
  ident: 1617_CR48
  publication-title: Proteomics
  doi: 10.1002/pmic.201800257
– volume: 8
  start-page: e2542
  year: 2017
  ident: 1617_CR39
  publication-title: Cell Death Dis
  doi: 10.1038/cddis.2016.467
– volume: 2017
  start-page: 1719050
  year: 2017
  ident: 1617_CR73
  publication-title: Stem Cells Int
  doi: 10.1155/2017/1719050
– volume: 65
  start-page: 161
  year: 2017
  ident: 1617_CR76
  publication-title: Brain Behav Immun
  doi: 10.1016/j.bbi.2017.04.024
– volume: 26
  start-page: 1476
  year: 2005
  ident: 1617_CR90
  publication-title: Electrophoresis
  doi: 10.1002/elps.200410140
– volume: 31
  start-page: F9
  year: 2017
  ident: 1617_CR45
  publication-title: AIDS
  doi: 10.1097/QAD.0000000000001595
– volume: 139
  start-page: 481
  year: 2016
  ident: 1617_CR23
  publication-title: Brain
  doi: 10.1093/brain/awv346
– volume: 254
  start-page: 1026
  year: 2007
  ident: 1617_CR14
  publication-title: J Neurol
  doi: 10.1007/s00415-006-0481-8
– volume: 18
  start-page: 538
  year: 2017
  ident: 1617_CR27
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms18030538
– volume: 67
  start-page: 699
  year: 2010
  ident: 1617_CR1
  publication-title: Ann Neurol
  doi: 10.1002/ana.22053
– volume: 7
  start-page: 4093
  year: 2015
  ident: 1617_CR32
  publication-title: Viruses
  doi: 10.3390/v7072810
– volume: 10
  start-page: 5
  year: 2012
  ident: 1617_CR46
  publication-title: J Transl Med
  doi: 10.1186/1479-5876-10-5
– volume: 12
  start-page: 526
  year: 2018
  ident: 1617_CR85
  publication-title: Front Cell Neurosci
  doi: 10.3389/fncel.2018.00526
– volume: 8
  start-page: 7227
  year: 2018
  ident: 1617_CR34
  publication-title: Sci Rep
  doi: 10.1038/s41598-018-25515-4
– volume: 111
  start-page: 1805
  year: 2003
  ident: 1617_CR81
  publication-title: J Clin Invest
  doi: 10.1172/JCI200318921
– volume: 11
  start-page: 68
  year: 2014
  ident: 1617_CR36
  publication-title: J Neuroinflammation
  doi: 10.1186/1742-2094-11-68
– volume: 25
  start-page: 69
  year: 2017
  ident: 1617_CR59
  publication-title: Top Antivir Med
– volume: 291
  start-page: 26589
  year: 2016
  ident: 1617_CR30
  publication-title: J Biol Chem
  doi: 10.1074/jbc.R116.757955
– volume: 8
  start-page: 276
  year: 2014
  ident: 1617_CR69
  publication-title: Front Cell Neurosci
– volume: 19
  start-page: 137
  year: 2011
  ident: 1617_CR7
  publication-title: Top Antivir Med
– volume: 166
  start-page: 64
  year: 2006
  ident: 1617_CR82
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.166.1.64
– volume: 17
  start-page: 22
  year: 2016
  ident: 1617_CR67
  publication-title: Nat Rev Neurosci
  doi: 10.1038/nrn.2015.1
– volume: 9
  start-page: 317
  year: 2017
  ident: 1617_CR29
  publication-title: Front Aging Neurosci
  doi: 10.3389/fnagi.2017.00317
– volume: 70
  start-page: 219
  year: 2015
  ident: 1617_CR43
  publication-title: J Acquir Immune Defic Syndr
  doi: 10.1097/QAI.0000000000000756
– volume: 535
  start-page: 551
  year: 2016
  ident: 1617_CR88
  publication-title: Nature
  doi: 10.1038/nature18928
– volume: 462
  start-page: 118
  year: 2016
  ident: 1617_CR25
  publication-title: Clin Chim Acta
  doi: 10.1016/j.cca.2016.09.001
– volume: 69
  start-page: 1789
  year: 2007
  ident: 1617_CR51
  publication-title: Neurology
  doi: 10.1212/01.WNL.0000287431.88658.8b
– volume: 69
  start-page: 29
  year: 2015
  ident: 1617_CR13
  publication-title: J Acquir Immune Defic Syndr
  doi: 10.1097/QAI.0000000000000532
– volume: 28
  start-page: 1579
  year: 2014
  ident: 1617_CR10
  publication-title: AIDS
  doi: 10.1097/QAD.0000000000000303
– volume: 206
  start-page: 275
  year: 2012
  ident: 1617_CR8
  publication-title: J Infect Dis
  doi: 10.1093/infdis/jis326
– volume: 36
  start-page: 1083
  year: 2001
  ident: 1617_CR52
  publication-title: J Mass Spectrom
  doi: 10.1002/jms.229
– volume: 62
  start-page: 1507
  year: 2018
  ident: 1617_CR22
  publication-title: J Alzheimers Dis
  doi: 10.3233/JAD-170953
– volume: 1
  start-page: 444
  year: 2001
  ident: 1617_CR56
  publication-title: Proteomics
  doi: 10.1002/1615-9861(200103)1:3<444::AID-PROT444>3.0.CO;2-Q
– volume: 4
  start-page: 837
  year: 2005
  ident: 1617_CR54
  publication-title: J Proteome Res
  doi: 10.1021/pr049750o
– volume: 5
  start-page: 976
  year: 1994
  ident: 1617_CR53
  publication-title: J Am Soc Mass Spectrom
  doi: 10.1016/1044-0305(94)80016-2
– volume: 2015
  start-page: 152926
  year: 2015
  ident: 1617_CR66
  publication-title: Biomed Res Int
  doi: 10.1155/2015/152926
– volume: 7
  start-page: S4
  issue: Suppl 1
  year: 2006
  ident: 1617_CR68
  publication-title: BMC Neurosci
  doi: 10.1186/1471-2202-7-S1-S4
– volume: 31
  start-page: 1365
  year: 2017
  ident: 1617_CR20
  publication-title: AIDS
  doi: 10.1097/QAD.0000000000001503
– volume: 11
  start-page: 600
  year: 2015
  ident: 1617_CR21
  publication-title: Alzheimers Dement
  doi: 10.1016/j.jalz.2014.06.008
– volume: 9
  start-page: 3
  year: 2012
  ident: 1617_CR18
  publication-title: Clin Proteomics
  doi: 10.1186/1559-0275-9-3
– volume: 11
  start-page: 26
  year: 2017
  ident: 1617_CR28
  publication-title: Front Neurosci
  doi: 10.3389/fnins.2017.00026
– volume: 1
  start-page: 1446
  year: 2007
  ident: 1617_CR87
  publication-title: Proteomics Clin Appl
  doi: 10.1002/prca.200700522
– volume: 53
  start-page: 146
  year: 2017
  ident: 1617_CR33
  publication-title: Infect Genet Evol
  doi: 10.1016/j.meegid.2017.05.021
– ident: 1617_CR35
  doi: 10.1016/j.neuroscience.2018.04.003
– volume: 22
  start-page: 179
  year: 2016
  ident: 1617_CR44
  publication-title: J Neuro-Oncol
– volume: 29
  start-page: 559
  year: 2015
  ident: 1617_CR9
  publication-title: AIDS
  doi: 10.1097/QAD.0000000000000580
– volume: 11
  start-page: e0157160
  year: 2016
  ident: 1617_CR12
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0157160
– volume: 12
  start-page: 309
  year: 2016
  ident: 1617_CR3
  publication-title: Nat Rev Neurol
  doi: 10.1038/nrneurol.2016.53
– volume: 60
  start-page: 234
  year: 2012
  ident: 1617_CR11
  publication-title: J Acquir Immune Defic Syndr
  doi: 10.1097/QAI.0b013e318256f3bc
– volume: 106
  start-page: 191
  year: 2014
  ident: 1617_CR47
  publication-title: J Proteome
  doi: 10.1016/j.jprot.2014.04.028
– volume: 82
  start-page: 2055
  year: 2014
  ident: 1617_CR4
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000000492
– volume: 3
  start-page: 1962
  year: 2003
  ident: 1617_CR91
  publication-title: Proteomics
  doi: 10.1002/pmic.200300463
– volume: 20
  start-page: 457
  year: 2014
  ident: 1617_CR19
  publication-title: J Neuro-Oncol
– volume: 6
  start-page: 1369805
  year: 2017
  ident: 1617_CR24
  publication-title: J Extracell Vesicles
  doi: 10.1080/20013078.2017.1369805
– volume: 22
  start-page: 703
  year: 2018
  ident: 1617_CR83
  publication-title: Expert Opin Ther Targets
  doi: 10.1080/14728222.2018.1501473
– volume: 2
  start-page: 569
  year: 2002
  ident: 1617_CR26
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri855
– volume: 72
  start-page: 610
  year: 2012
  ident: 1617_CR77
  publication-title: Ann Neurol
  doi: 10.1002/ana.23627
– volume: 8
  start-page: 1162
  year: 2016
  ident: 1617_CR63
  publication-title: EMBO Mol Med
  doi: 10.15252/emmm.201606271
– volume: 4
  start-page: 2123
  year: 2013
  ident: 1617_CR64
  publication-title: Nat Commun
  doi: 10.1038/ncomms3123
– volume: 189
  start-page: 744
  year: 2012
  ident: 1617_CR40
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1102244
– volume: 20
  start-page: 282
  year: 2012
  ident: 1617_CR61
  publication-title: Trends Microbiol
  doi: 10.1016/j.tim.2012.03.009
– volume: 3
  start-page: 124
  year: 2012
  ident: 1617_CR31
  publication-title: Front Physiol
  doi: 10.3389/fphys.2012.00124
– volume: 15
  start-page: 19
  year: 2018
  ident: 1617_CR71
  publication-title: Fluids Barriers CNS
  doi: 10.1186/s12987-018-0104-7
SSID ssj0032562
Score 2.4963987
Snippet Extracellular vesicles (EVs) are nano-sized particles present in most body fluids including cerebrospinal fluid (CSF). Little is known about CSF EV proteins in...
Background Extracellular vesicles (EVs) are nano-sized particles present in most body fluids including cerebrospinal fluid (CSF). Little is known about CSF EV...
Abstract Background Extracellular vesicles (EVs) are nano-sized particles present in most body fluids including cerebrospinal fluid (CSF). Little is known...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 254
SubjectTerms Apolipoproteins
Astrocytes
Biomarkers
Blood-brain barrier
Body fluids
Brain
Brain mapping
Cell culture
Cell Line, Tumor
Cerebrospinal fluid
Chemokines
Choroid plexus
Cognition
Cognitive ability
Cognitive Dysfunction - cerebrospinal fluid
Cognitive Dysfunction - genetics
Cognitive Dysfunction - psychology
Cognitive impairment
CSF
Cytokines
Electron microscopy
Extracellular vesicles
Extracellular Vesicles - genetics
Extracellular Vesicles - metabolism
Female
Gene mapping
Genes
Glial cells
Glial fibrillary acidic protein
Heat shock proteins
HIV
HIV Infections - cerebrospinal fluid
HIV Infections - genetics
HIV Infections - psychology
HIV patients
Hsp70 protein
Human immunodeficiency virus
Humans
Hydrogen peroxide
Immunoblotting
Immunological synapses
Inflammation
Inflammation - cerebrospinal fluid
Inflammation - genetics
Inflammation - psychology
Male
Mass spectrometry
Mass spectroscopy
Microscopy
Middle Aged
Mitochondria
Multiple sclerosis
Nanoparticles
Neuronal-glial interactions
Neurons
Oxidative stress
Oxidative Stress - physiology
PARK7 protein
Pathogenesis
Peptide mapping
Peroxides
Proteins
Proteomes
Proteomics
Proteomics - methods
Scientific imaging
Shock
Spectroscopy
Synapses
Synapses - genetics
Synapses - metabolism
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEA9yD-KL-G31lAiCIFdumzRp-niKxyooPnhybyGfuHLXlXZX2D_K_9GZNFu2CPoi-1DYTLqbzGQ-kplfCHkprYvg1cYSbBkEKB5WehsQyLXiUTgrvPIpQfaTXF7UHy7F5cFVX5gTNsIDjxN3yqQDi9JWhjtfx-gVl9GAkIbWBBVjqiMHm7cPpkYdzMGQs3yGWSl5OoBVazDboi3Rny93MyuUwPr_VMkHNmmeL3lggM7vkNvZc6Rn4z--S26E7h65-TGfjd8nvz4j5AIWGVOTkUboOlIXegh78XYQ7B2vtitPQSH3BrfsMQeV_gxDyo2jiOYE0kiHXWdAkzi66r7DlJ_AM4LgjEWOJ_B2T8cSE-iRMmwDvcYsn34ASrp8_5VmtNaB4jYvnVKUKNZkrnrckHxALs7ffXm7LPNlDKUDp2gDWtNUlsOKt7WtWGyYaaKCjzRW1sorF1lrrIh1dAGCLmW4EsJwcChUG4Oo-ENy1K278JhQ601gVtShYqYGd8wI47ngTRWjCmyhCrLYM0e7jFSOF2Zc6RSxKKlHfmrgp0Z-6l1BXk9dfowwHX8jfoMcnwgRYTt9AXKns9zpf8ldQV6hvGjUA8gzk8sZYIiIqKXP5KJp4Xd5XZDjGSWsXzdv3kuczvpj0ODnqho8acUK8mJqxp6YE9eF9TbRMDxmbWVBHo0COg0JNDX4zQKmspmJ7mzM85Zu9S2hi0sFEbAUT_7HJD0lt1hadKxciGNytOm34Rk4cRv7PK3X35Q_Sk4
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bb9MwFLbGkBAvaOMaNpCRkJDQAo0dO84DQhtiKkhDPFC0N8tx7FFUUkhaRH8U_5FzHDdaxDT1oVJtt3XO7Tv28WdCnsvKekC1PoVYBglKDZZeOiRyzbgXthK1qkOB7Cc5neUfz8X5DtlebxUfYHdlaof3Sc3axas_vzZvweDfBINX8nUHMavAWooyRbSebm6QmxCYCrTTs3zYVOAQ3Vnc2Lxy2Cg0BQb___30pUA1LqK8FJVO98idCCfpcS__fbLjmrvk1lncML9H_n5GHgY8eUxNpB-hS0-tayEXxitDcLRfrOc1BS_dGlzHx8JU-tt1oWCOIsUTPCrabRoD7sXSefMd5HAE7x60qT_5eATfXtP-3AmMCGW3jv7A0p-2g550-uErjRSuHcW1XzrULVE8qDlvcZXyPpmdvv_ybprGGxpSC0hpBa7UZBUHN1DlVcZ8wUzhFbykqWSuamU9K00lfO6tg0xMGa6EMBxQhiq9Exl_QHabZeMeEVrVxrFK5C5jJgeMZoSpueBF5r1ybKISMtkKR9tIX463aCx0SGOU1L08NchTozz1JiEvhyE_e-6O6zqfoMSHjki7HT5Ythc6WrFm0gK8KTPDbZ17XysuvQGP6UrjlPdFQl6gvmhUV5SZiWccYIpIs6WP5aQo4Xd5npDDUU8wajtu3mqc3tqEBvCrcoDXiiXk2dCMI7FQrnHLdejDcO-1lAl52CvoMCVw3wCmBTzKYqS6ozmPW5r5t0A5LhWkxVI8vv5vHZDbLJgTSyfikOyu2rV7AphtVT0NlvgPb2REHQ
  priority: 102
  providerName: Scholars Portal
Title Proteomic analysis of cerebrospinal fluid extracellular vesicles reveals synaptic injury, inflammation, and stress response markers in HIV patients with cognitive impairment
URI https://www.ncbi.nlm.nih.gov/pubmed/31805958
https://www.proquest.com/docview/2328457582
https://www.proquest.com/docview/2322739596
https://pubmed.ncbi.nlm.nih.gov/PMC6896665
https://doaj.org/article/26c85391a3cd4ffd836fa305e9ae8ff7
Volume 16
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3ta9QwGA-6gfhFfLc6jwiCICu7Jk2afpJNNk5hY4iT-xbSNJknszfbO-H-KP9HnyfN1RVhHPTgkvSaPu9PnvxCyFtZWQ9erU_BlkGAUoOklw6BXDPuha1ErepQIHsmZxf557mYx4RbF8sqtzoxKOp6aTFHfgCWX-XgWyj24fpXiqdG4epqPELjLtlF6DIs6SrmQ8DFwZyzuJKZKXnQgW0rsOaiTNGrTzcjWxQg-_9XzDcs07hq8oYZOnlIHkT_kR72BH9E7rjmMbl3GlfIn5A_5wi8gFuNqYl4I3TpqXUtBL94RgiO9lfrRU1BLbcGE_dYiUp_uy5UyFHEdAKepN2mMaBPLF00P-DF78O3B_bptzruw91r2m80gRGhztbRn1jr03bQk84-faMRs7WjmOylQ6ESxZ2ZixbTkk_Jxcnx14-zNB7JkFpwjVagO01WcZD7Kq8y5gtmCq_gI00lc1Ur61lpKuFzbx2EXspwJYTh4Fao0juR8Wdkp1k27gWhVW0cq0TuMmZycMqMMDUXvMi8V45NVUKmW-JoG_HK8diMKx3iFiV1T08N9NRIT71JyPthyHUP1nFb5yOk-NARcbbDD8v2Ukex1Uxa8GfKzHBb597XiktvQEW60jjlfZGQd8gvGrUB0szETQ0wRcTV0odyWpTwvzxPyN6oJ0ixHTdvOU5HLdLpfzyfkDdDM47EyrjGLdehD8PF1lIm5HnPoMOUQF-D9yzgVRYj1h3NedzSLL4HjHGpIA6W4uXtj_WK3GdBnFg6FXtkZ9Wu3Wtw0lbVJEjihOweHZ-df5mEVAdcT3P1F3sKREg
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLZGJwEviDuBAUYCIaFFa-zYcR4Q2mBTyy6a0Ib25jmODUUjHUkL6o-C38g5uZRFSHub-lCpttO65_KdY58LIS9lZj1YtT4ELAMHJQdJTx0Wco24FzYTucrrANkDOTqOP56IkxXyp8uFwbDKTifWijqfWjwj3wDkVzHYFoq9O_8RYtcovF3tWmg0bLHrFr_AZavejj8AfV8xtrN99H4Utl0FQgvoPgPxN1HGgXWzOIuYT5hJvIKXNJmMVa6sZ6nJhI-9deA9KMOVEIYDMqrUOxFxeO41shpzcGUGZHVr--DwU6f7ORgQrL07jZTcqABNE4zySEP0I8JFD_3qJgH_Q8EFLOzHaV4Avp3b5FZrsdLNhsXukBVX3CXX99s7-Xvk9yGWesDkZmraCid06ql1Jbjb2JUEV_uz-SSnAASlwasCjH2lP11Vx-RRrCIFUkCrRWFAg1k6Kb4Bqdfh3QPDNsmV6_D0nDapLbCijux19DtGF5UVzKSj8WfaVomtKB4v02VoFMVc0EmJB6H3yfGVkOsBGRTTwj0iNMuNY5mIXcRMDGagESbngieR98qxoQrIsCOOtm2FdGzUcaZrT0lJ3dBTAz010lMvAvJmueS8KQ9y2eQtpPhyIlb2rj-Yll90qyg0kxYsqDQy3Oax97ni0htQyi41TnmfBOQ18otG_YM0M20aBWwRK3npTTlMUvheHgdkrTcT9IbtD3ccp1u9Vel_UhaQF8thXImxeIWbzus5DK93UxmQhw2DLrcECAH2uoC_Mumxbm_P_ZFi8rWuai4VeN5SPL78Zz0nN0ZH-3t6b3yw-4TcZLVosXAo1shgVs7dUzARZ9mzVi4pOb1qVfAXm_B_BA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Proteomic+analysis+of+cerebrospinal+fluid+extracellular+vesicles+reveals+synaptic+injury%2C+inflammation%2C+and+stress+response+markers+in+HIV+patients+with+cognitive+impairment&rft.jtitle=Journal+of+neuroinflammation&rft.au=Guha%2C+Debjani&rft.au=Lorenz%2C+David+R&rft.au=Misra%2C+Vikas&rft.au=Chettimada%2C+Sukrutha&rft.date=2019-12-05&rft.pub=BioMed+Central&rft.eissn=1742-2094&rft.volume=16&rft.spage=1&rft_id=info:doi/10.1186%2Fs12974-019-1617-y
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1742-2094&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1742-2094&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1742-2094&client=summon